Apar Kishor Ganti

机构：Nebraska Medical Center, VA Nebraska Western Iowa Health Care System, University of Nebraska Medical Center · ORCID：0000-0003-3724-2671

发表论文 463 篇 · 总被引 12462 次 · h-index 48

代表论文

• ST6GalNAc-I regulates tumor cell sialylation via NECTIN2/MUC5AC-mediated immunosuppression and angiogenesis in non–small cell lung cancer (2025 · Journal of Clinical Investigation · 被引 21)
• SWOG/NRG S1914: Randomized phase III trial of induction/consolidation atezolizumab + SBRT versus SBRT alone in high risk, early-stage NSCLC. (2025 · Journal of Clinical Oncology · 被引 20)
• Randomized phase II study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small-cell lung cancer (NSCLC): Big Ten Cancer Research Consortium LUN16-081 (2025 · Journal for ImmunoTherapy of Cancer · 被引 10)
• Therapeutic Potential of Datopotamab Deruxtecan in the Treatment of Advanced Non-Small Cell Lung Cancer: Evidence to Date (2025 · OncoTargets and Therapy · 被引 9)
• Combination Immunotherapy With Radiotherapy in Non‐Small Cell Lung Cancer: A Review of Evidence (2024 · Cancer Medicine · 被引 7)
• Perceived Barriers, Facilitators, and Needs Related to Promoting Physical Activity in Cancer Care: Qualitative Insights from Oncology Care Providers (2025 · Cancers · 被引 5)